Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

On-Premise and Remote Robotic Neurointervention

NCT06365554 · Remedy Robotics, Inc. · Updated 15 April 2024

What is being tested
Remedy Robot
For
Cerebrovascular Disease
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 10 people. The full rules are on the registry page.
Where
Not stated
When
Starts or started 1 June 2024, ends 1 June 2025. Registered 15 April 2024.
Results
None posted yet.

In the researchers' words

This study is a prospective, single arm, single-center study to evaluate the safety and feasibility of the Remedy Robot for on premise and remote robotic Neurointervention.
ClinicalTrials.gov, NCT06365554